Contact
searchSearch
HMP Global

Gout News

Research Highlights
Nearly Half of Patients With Gout Have Metabolic Syndrome
03/18/2026
Jessica Garlewicz
Recent analysis underscores the need for broader cardiometabolic assessment in gout management and reinforce gout as a multisystem disease.
Recent analysis underscores the need for broader cardiometabolic assessment in gout management and reinforce gout as a multisystem disease.
Recent analysis underscores the...
03/18/2026
Rheumatology & Arthritis
Research Review
Gout and Psoriatic Disease Overlap Presents Diagnostic and Management Challenges
02/17/2026
Jessica Garlewicz
The coexistence of gout and psoriatic disease (PD) is increasingly recognized in clinical practice, with overlapping phenotypes and shared comorbidities complicating diagnosis and treatment decisions.
The coexistence of gout and psoriatic disease (PD) is increasingly recognized in clinical practice, with overlapping phenotypes and shared comorbidities complicating diagnosis and treatment decisions.
The coexistence of gout and...
02/17/2026
Rheumatology & Arthritis
Research Highlights
Achieving Serum Urate Target Linked to Lower Cardiovascular Risk in Gout
02/17/2026
Jessica Garlewicz
Patients with gout who achieved serum urate levels below 6 mg/dL within 12 months of starting urate-lowering therapy (ULT) had a lower 5-year risk of major adverse cardiovascular events compared with those who did not reach target, according...
Patients with gout who achieved serum urate levels below 6 mg/dL within 12 months of starting urate-lowering therapy (ULT) had a lower 5-year risk of major adverse cardiovascular events compared with those who did not reach target, according...
Patients with gout who achieved...
02/17/2026
Rheumatology & Arthritis
Research Summary
Gout Associated With Higher Risk of Long-Term Opioid Use in Veterans Cohort
02/13/2026
Jessica Garlewicz
Patients with gout are significantly more likely to receive long-term opioid prescriptions compared with individuals without gout, according to a large matched cohort study using national Veterans Health Administration data.
Patients with gout are significantly more likely to receive long-term opioid prescriptions compared with individuals without gout, according to a large matched cohort study using national Veterans Health Administration data.
Patients with gout are...
02/13/2026
Rheumatology & Arthritis
News
Treat-to-Target Urate-Lowering Therapy Improves Quality of Life in Gout
02/13/2026
Jessica Garlewicz
The findings provide patient-centered evidence supporting guideline-recommended, protocolized gout management.
The findings provide patient-centered evidence supporting guideline-recommended, protocolized gout management.
The findings provide...
02/13/2026
Rheumatology & Arthritis
Research Highlights
Emerging Microbiome Insights Suggest Novel Adjunct Targets in Gout Management
01/14/2026
Jessica Garlewicz
Growing evidence links alterations in the intestinal microbiome to hyperuricemia and gout, raising interest in whether microbiome-targeted strategies could complement established urate-lowering therapies.
Growing evidence links alterations in the intestinal microbiome to hyperuricemia and gout, raising interest in whether microbiome-targeted strategies could complement established urate-lowering therapies.
Growing evidence links...
01/14/2026
Rheumatology & Arthritis
News
Febuxostat Linked to Higher Hepatotoxicity Risk Than Benzbromarone in Gout Patients
09/15/2025
Riya Gandhi, MA
A propensity score–matched cohort study reveals that febuxostat use carries a significantly higher risk of liver enzyme abnormalities than benzbromarone, particularly among patients with pre-existing liver function elevations.
A propensity score–matched cohort study reveals that febuxostat use carries a significantly higher risk of liver enzyme abnormalities than benzbromarone, particularly among patients with pre-existing liver function elevations.
A propensity score–matched...
09/15/2025
Rheumatology & Arthritis
News
Colchicine Drug Levels Not Predictive of Efficacy or Side Effects in Gout Flare Prevention
09/15/2025
Riya Gandhi, MA
A post hoc analysis of a randomized clinical trial finds no consistent link between plasma colchicine concentrations and flare prevention or adverse effects—challenging the utility of therapeutic drug monitoring in routine gout care.
A post hoc analysis of a randomized clinical trial finds no consistent link between plasma colchicine concentrations and flare prevention or adverse effects—challenging the utility of therapeutic drug monitoring in routine gout care.
A post hoc analysis of a...
09/15/2025
Rheumatology & Arthritis
Research Highlights
Only One-Third of Gout Flare Patients Follow Up After ED Visit, Study Finds
09/15/2025
Riya Gandhi, MA
New research identifies social and clinical factors—such as marital status, age, and colchicine use—that may influence whether patients seek outpatient care after visiting the emergency department for a gout flare.
New research identifies social and clinical factors—such as marital status, age, and colchicine use—that may influence whether patients seek outpatient care after visiting the emergency department for a gout flare.
New research identifies social...
09/15/2025
Rheumatology & Arthritis
News
Time Trends and Predictors of Gout Remission
09/04/2025
Rebecca Mashaw
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Gout remission rates steadily...
09/04/2025
Rheumatology & Arthritis

Popular Articles

News
Risk of Cardiovascular Disease May be Easing in Patients With PsA
11/08/2024
Rebecca Mashaw
Meta-regression showed a lower rate of incident cardiovascular disease in more recent data for patients with psoriatic arthritis, but not for patients with spondyloarthritis, researchers report.
Meta-regression showed a lower rate of incident cardiovascular disease in more recent data for patients with psoriatic arthritis, but not for patients with spondyloarthritis, researchers report.
Meta-regression showed a lower...
11/08/2024
Rheumatology & Arthritis
News
Serum Biomarkers Linked With IBD-Associated axSpA
09/23/2024
Jolynn Tumolo
The genetic variant NOD2/CARD15 polymorphism appears related to subclinical intestinal inflammation in patients with axial spondyloarthritis.
The genetic variant NOD2/CARD15 polymorphism appears related to subclinical intestinal inflammation in patients with axial spondyloarthritis.
The genetic variant NOD2/CARD15...
09/23/2024
Rheumatology & Arthritis
FDA Alert
FDA Approves Bimekizumab for PsA, nr-axSpA and AS
09/23/2024
Rebecca Mashaw
Already approved for plaque psoriasis, bimekizumab is designed to selectively inhibit interleukin 17A (IL-17A) and interleukin 17F (IL-17F).
Already approved for plaque psoriasis, bimekizumab is designed to selectively inhibit interleukin 17A (IL-17A) and interleukin 17F (IL-17F).
Already approved for plaque...
09/23/2024
Rheumatology & Arthritis
Poll
Assessing Bone Loss in Patients With axSpA
12/05/2024
Rebecca Mashaw
Bone loss has been found to play a significant role in axial spondyloarthritis (axSpA) and regular assessments are recommended. How do you assess bone loss in your patients with axSpA?DXA scanTrabecular bone score Quantitative computed...
Bone loss has been found to play a significant role in axial spondyloarthritis (axSpA) and regular assessments are recommended. How do you assess bone loss in your patients with axSpA?DXA scanTrabecular bone score Quantitative computed...
Bone loss has been found to play...
12/05/2024
Rheumatology & Arthritis
News
ASAS Issues Consensus Recommendations for Imaging in axSpA
10/10/2024
Rebecca Mashaw
Task force produces guidelines focusing on critical elements to help enhance diagnosis and patient care in axial spondyloarthritis.
Task force produces guidelines focusing on critical elements to help enhance diagnosis and patient care in axial spondyloarthritis.
Task force produces guidelines...
10/10/2024
Rheumatology & Arthritis

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use